SCHEMBL1825843

SCHEMBL1825843

CCOC(=O)CC(CNC(C)=O)c1ccc(OS(C)(=O)=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 3/20 0.39
F10 P00742 2/20 0.39
MTNR1A P48039 4/20 0.39
MTNR1B P49286 4/20 0.39
STS P08842 1/20 0.39
PPARG P37231 3/20 0.38
ACACB O00763 1/20 0.37
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
PPARA Q07869 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP7 P09237 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824407 0.89 MTNR1A (0.41) MTNR1AMTNR1BSTSACACBCA1
SCHEMBL1825194 0.86 MTNR1A (0.48) F2F10MTNR1AMTNR1BALDH1A1
SCHEMBL1823783 0.86 MTNR1A (0.39) MTNR1AMTNR1BACACBCA12CA1
SCHEMBL1826940 0.85 SYK (0.40) F2F10STSPPARGGAA
SCHEMBL1825011 0.85 ENPP1 (0.42) PPARGGAAKDM4EALDH1A1HTT
SCHEMBL1826195 0.85 MTNR1A (0.48) MTNR1AMTNR1BPPARGACACBCA12
SCHEMBL1825078 0.85 ALDH1A1 (0.44) F2MTNR1AMTNR1BPPARGKDM4E
SCHEMBL1824474 0.85 MTNR1A (0.38) MTNR1AMTNR1BACACBCA12CA1
SCHEMBL1824126 0.83 CA1 (0.45) F2PPARGCA12CA1CA2
SCHEMBL1823765 0.81 STS (0.44) MTNR1AMTNR1BSTSPPARGACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 F2 701/4885F10 1460/4885MTNR1A 2715/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 F2 805/4885F10 1977/4885MTNR1A 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.